Quelle place pour la radioembolisation Yttrium 90 dans le traitement des métastases hépatiques du cancer colorectal ?

In the treatment of unresectable liver metastases of colorectal cancer, radioembolization with SIR-Spheres confirms its place in the treatment of refractory disease with a gain in terms of response, progression-free survival, and also overall survival. In combination with first-line systemic standard chemotherapy (FOLFOX6m ± bevacizumab), the results of SIRFLOX study show an improvement in hepatic control (objective response rate and liver progression-free survival) without gain in progression-free survival at any site.